Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
The cancer immunoediting hypothesis assumes the immune system sculpts the cancer genome. Here the authors show, in a mouse model, that neutral evolution outweighs the effects of immunoselection and that immune checkpoint blockade potentiates the immunoediting, switching the system to non-neutral evo...
Guardado en:
Autores principales: | Mirjana Efremova, Dietmar Rieder, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Hubert Hackl, Natascha Hermann-Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam, Zlatko Trajanoski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e257159229014b539553cb86455044f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
por: Victoria Klepsch, et al.
Publicado: (2018) -
Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
por: Katarzyna Wachowicz, et al.
Publicado: (2014) -
IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Kazuyoshi Takeda, et al.
Publicado: (2017) -
LAMTOR2-mediated modulation of NGF/MAPK activation kinetics during differentiation of PC12 cells.
por: Bettina Thauerer, et al.
Publicado: (2014) -
Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories
por: Shinichi Mizuno, et al.
Publicado: (2021)